PriceTargets.com logo

Maricann Group - MARI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.25
  • Forecasted Upside: ∞
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 03/14/2019 08:48 AM ET
+0 (0.00%)

This chart shows the closing price for MARI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Maricann Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MARI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MARI

Analyst Price Target is $6.25
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Maricann Group in the last 3 months. The average price target is $6.25, with a high forecast of $6.50 and a low forecast of $6.00. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for MARI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Maricann Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/23/2024Raymond JamesBoost Target$6.00 ➝ $6.50
1/12/2024Canaccord Genuity GroupLower TargetSpeculative Buy$6.50 ➝ $6.00
10/14/2022Royal Bank of CanadaBoost TargetOutperform$5.00 ➝ $5.50
9/26/2022Royal Bank of CanadaSet TargetOutperform$5.00
10/13/2021Raymond JamesLower TargetOutperform$6.00 ➝ $5.50
9/9/2021Raymond JamesSet TargetOutperform$6.00
6/16/2021Raymond JamesSet TargetOutperform$6.00
6/9/2021Raymond JamesBoost TargetOutperform$5.50 ➝ $6.00
5/20/2021Raymond JamesSet TargetOutperform$5.50
5/6/2021Raymond JamesSet TargetOutperform$5.50
4/21/2021Raymond JamesSet TargetOutperform$5.50
(Data available from 4/23/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Maricann Group logo
Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company's services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

682,578 shs

Average Volume

142,686 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Maricann Group?

The following sell-side analysts have issued research reports on Maricann Group in the last twelve months: Canaccord Genuity Group Inc., and Raymond James.
View the latest analyst ratings for MARI.

What is the current price target for Maricann Group?

2 Wall Street analysts have set twelve-month price targets for Maricann Group in the last year. Their average twelve-month price target is $6.25. Raymond James has the highest price target set, predicting MARI will reach $6.50 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of $6.00 for Maricann Group in the next year.
View the latest price targets for MARI.

What is the current consensus analyst rating for Maricann Group?

Maricann Group currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MARI will outperform the market and that investors should add to their positions of Maricann Group.
View the latest ratings for MARI.

How do I contact Maricann Group's investor relations team?

Maricann Group's physical mailing address is 845 Harrington Crt Unit 3, BURLINGTON, ON L7N 3P3, Canada. The company's listed phone number is +1-289-2886284. The official website for Maricann Group is www.maricann.com. Learn More about contacing Maricann Group investor relations.